Table 1.
Women cancer survivors participating in a proof-of-concept implementation pilot study
Variable | Women Cancer Survivors (N=16)a |
---|---|
| |
Age (years) | 58 ± 12 (37 – 83) |
Ethnicity | |
Not Hispanic/Latino | 11 (100) |
Race | |
White/Caucasian | 10 (62) |
Black/African American | 6 (38) |
Income | |
≤ $20,000 | 5 (31) |
> $20,000 to < $50,000 | 4 (25) |
≥ $50,000 | 6 (38) |
Missing | 1 (6) |
Education | |
≤ 12 years | 5 (31) |
13 – 16 years | 6 (38) |
> 16 years | 5 (31) |
Mean number of comorbidities | 2.5 ± 1.6 (0 – 5) |
Marital status | |
Married | 11 (69) |
Not married or partnered | 5 (31) |
Current smoker (yes) | 0 (0) |
Alcohol (yes) | 3 (19) |
Cancer type | |
Breast | 11 (69) |
Other (melanoma, lung, leukemia, uterine, cervical) | 5 (31) |
Cancer stage | |
0 or 1 | 4 (25) |
2 | 7 (44) |
3 | 2 (12) |
Missing or unknown | 3 (19) |
Months since cancer diagnosis | 54 ± 72 (11 to 300) |
Prior cancer surgery (yes) | 14 (88) |
Prior radiation therapy (yes) | 11 (69) |
Prior chemotherapy (yes) | 10 (63) |
Distance from home to implementation site b | 10 ± 10 (3 – 35) |
Distance from job to implementation site b, c | 11 ± 15 (0 – 40) |
Values presented as mean ± standard deviation (range) or number (percent).
Distance from home and job to the implementation site reported in miles.
Participants who were employed (n = 7).